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Summary
In patients with STEMI, CMR parameters such as
infarct size, MO and the MSI add incremental prognos-
tic value above traditional outcome markers.
Background
Infarct size, microvascular obstruction (MO) and the
myocardial salvage index (MSI) assessed by cardiac mag-
netic resonance imaging (CMR) have been shown to be
associated with adverse clinical outcome. However, in
daily clinical routine prognosis after STEMI is evaluated
using simple assessable parameters such as ST-segment
resolution, enzymatic infarct size, pre- and post-PCI
TIMI-flow, left ventricular ejection fraction (LV EF) and
TIMI-risk score. Up to date it remains unclear if the
assessment of infarct size, MO and MSI by CMR adds
incremental prognostic value in comparison to the tradi-
tional outcome markers.
Methods
STEMI patients reperfused by primary angioplasty
(n=392) within 12 hours after symptom onset under-
went CMR 3 days after the index event (interquartile
range [IQR] 2-4). Infarct size and MO were measured
15 min after gadolinium injection. T2-weighted and
contrast-enhanced CMR was then used to calculate
MSI. In all patients ST-resolution, pre- and post-PCI
TIMI-flow, as well as the enzymatic infarct size using
creatine kinase-MB were recorded. All patients under-
went transthoracic echocardiography for the assessment
of LV EF. Finally the TIMI-risk score was calculated.
Clinical follow-up was conducted after 19 months (IQR
10-27). The primary endpoint was defined as a compo-
site of death, myocardial reinfarction and congestive
heart failure. C-statistics were computed to assess the
prognostic value of different models regarding the
occurrence of the primary endpoint.
Results
Comparison of a model including only traditional out-
come markers (model 1: ST-resolution, enzymatic
infarct size, pre- and post-PCI TIMI-flow, LV EF and
TIMI-risk score) to a model including only CMR para-
meters (model 2: infarct size, MO and MSI) revealed an
increase of the corresponding c-statistics (model 1: 0.68
vs. model 2: 0.73, p=0.03). Comparison of model 1 to a
model including the CMR parameters on top of tradi-
tional outcome markers (model 3) demonstrated an
incremental prognostic value of infarct size, MO and
MSI (model 1: 0.68 vs. model 3: 0.77, p=0.02).
Conclusions
In patients with STEMI, CMR parameters such as
infarct size, MO and the MSI add incremental prognos-
tic value above traditional outcome markers.
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